Spine slenderness is not an early sign of progression in adolescent idiopathic scoliosis
- PMID: 36195358
- DOI: 10.1016/j.medengphy.2022.103879
Spine slenderness is not an early sign of progression in adolescent idiopathic scoliosis
Abstract
Adolescent idiopathic scoliosis (AIS) is a three-dimensional deformity of the spine. Spine slenderness, which represents its potential instability to buckling under compressive loads, was shown to be higher in AIS patients than non-scoliotic subjects, but it is not clear at what stage of the progression this difference appeared, nor if slenderness could be used as an early sign of progression. In this study, we hypothesized that slenderness could be an early sign of progression. One-hundred thirty-eight patients and 93 non-scoliotic subjects were included. They underwent standing biplanar radiography and 3D reconstruction of the spine, which allowed computing vertebra and disc slenderness ratio. Then, patients were followed until progression of the deformity or skeletal maturity (stable patients). Vertebral slenderness ratio in AIS patients varied between 2.9 [2.7; 3.0] (T9) and 3.4 [3.2; 3.6] (T1), while disc slenderness ranged from 0.6 [0.6; 0.7] at T6-T7 to 1.2 [1.1; 1.3] at L4-L5. Slenderness ratio increased with age, while disc slenderness tended to decrease with age and Cobb angle. Slenderness was similar between progressive and stable patients, and also between patients and non-scoliotic subjects. In conclusion, spinal slenderness does not appear to be an early sign of progression. Further studies should analyse the development of slenderness during growth, and how it could be affected by non-operative treatment.
Keywords: 3D reconstruction; Biplanar radiography; Buckling; Mechanical instability.
Copyright © 2022 IPEM. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration Competing Interest Dr. Skalli has a patent related to biplanar X-Rays and associated 3D reconstruction methods, with no personal financial benefit (royalties rewarded for research and education) licensed to EOS Imaging. Dr. Vialle reports personal fees and grants (unrelated to this study) from EOS Imaging. Prof. Luca Maria Sconfienza has unrelated financial relationships with Esaote,Samsung Medison, Bracco Imaging Italia, Pfizer, Abiogen, Fidia Pharma Group, Novartis, Janssen-Cilag, MSD, Merck Serono
MeSH terms
LinkOut - more resources
Full Text Sources
Medical